Eliquis lowers stroke, major bleeding in older NVAF patients

By Jaime De Leon | Aug 30, 2017 | 12:50 AM GMT

Bristol-Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) said a real-world analysis of patients ages 65 and older with non-valvular atrial fibrillation (NVAF) showed that Eliquis apixaban

Read the full 274 word article

How to gain access

Continue reading with a
two-week free trial.